Who is Dr. Chrysostomos L. Nikias and why was he appointed to the Board?

Dr. Chrysostomos L. Nikias is the president of the University of Southern California. His appointment to Synopsys' Board of Directors on July 11, 2011, likely aims to strengthen the board's expertise and leadership with his significant experience in a large, complex organization.

What compensation will Dr. Nikias receive as a director?

As a non-employee director, Dr. Nikias will receive an annual cash retainer of $125,000, paid quarterly. He will also receive an initial stock option award for 30,000 shares and an annual equity award valued at $125,000, which will be prorated for his partial service in the current year.

What is the purpose of the new indemnification agreement?

The new indemnification agreement, approved by the Board of Directors on July 11, 2011, is designed to provide enhanced legal and financial protection to Synopsys' directors and executive officers. It ensures they are indemnified against potential claims arising from their service to the company, to the maximum extent allowed by law and the company's bylaws, and includes provisions for advancing legal expenses.

Does the new indemnification agreement change the company's liability?

The agreement aims to indemnify directors and officers to the fullest extent permitted by law. While it provides assurance to these individuals, it does not necessarily change Synopsys' underlying legal obligations or liabilities; rather, it clarifies and formalizes the company's commitment to protect its leadership against certain risks associated with their roles.

SNPS 8-K: Leadership Changes

Summary

This 8-K filing from Synopsys Inc. (SNPS) primarily reports on two significant corporate governance actions taken on July 11, 2011. Firstly, the company announced the appointment of Dr. Chrysostomos L. Nikias, president of the University of Southern California, to its Board of Directors. This appointment brings external leadership experience to the board, with Dr. Nikias set to receive standard compensation for non-employee directors, including a cash retainer and equity awards. Secondly, Synopsys' Board of Directors approved a new, updated form of indemnification agreement for all directors and executive officers. This agreement enhances the protections provided to these individuals by Synopsys, ensuring they are indemnified against claims related to their roles to the fullest extent permitted by law and company bylaws, and includes provisions for expense advancement. These actions reflect Synopsys' commitment to strong corporate governance and attracting experienced leadership.

Key Highlights

1Appointment of Dr. Chrysostomos L. Nikias to the Board of Directors, effective July 11, 2011.
2Dr. Nikias brings leadership experience from his role as president of the University of Southern California.
3Standard compensation for Dr. Nikias includes a $125,000 annual cash retainer and an annual equity award valued at $125,000 (prorated).
4Dr. Nikias also received an initial stock option award for 30,000 shares.
5Approval of a new form of indemnification agreement for directors and executive officers.
6The new agreement aims to indemnify individuals to the fullest extent permitted by law and company bylaws.
7The agreement includes provisions for the advancement of expenses related to potential claims.

SYNOPSYS INC 8-K Report, Executive Changes (Jul 14, 2011)

Summary

Key Highlights

Frequently Asked Questions